Kim J, Shin M, Lee S, Kim D, Choi K, Suh D
Int J Mol Sci. 2023; 24(12).
PMID: 37373457
PMC: 10299649.
DOI: 10.3390/ijms241210306.
Narasimhan M, Khamkar V, Tilwani S, Dalal S, Shetty D, Subramanian P
J Cell Commun Signal. 2021; 16(2):207-222.
PMID: 34596797
PMC: 8891420.
DOI: 10.1007/s12079-021-00647-x.
Luckstadt W, Bub S, Koudelka T, Pavlenko E, Peters F, Somasundaram P
Front Cell Dev Biol. 2021; 9:622390.
PMID: 33738281
PMC: 7960916.
DOI: 10.3389/fcell.2021.622390.
Hagiwara S, Sasaki E, Hasegawa Y, Suzuki H, Nishikawa D, Beppu S
Cancer Med. 2021; 10(4):1335-1346.
PMID: 33565282
PMC: 7926025.
DOI: 10.1002/cam4.3737.
Taki T, Shiraki Y, Enomoto A, Weng L, Chen C, Asai N
Cancer Sci. 2020; 111(12):4616-4628.
PMID: 33007133
PMC: 7734007.
DOI: 10.1111/cas.14673.
Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes.
Thomas S, Friedrich B, Schnaubelt M, Chan D, Zhang H, Aebersold R
iScience. 2020; 23(6):101079.
PMID: 32534439
PMC: 7298555.
DOI: 10.1016/j.isci.2020.101079.
RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M, Sun L, Li J, Yu H, Lin H, Yu T
J Exp Clin Cancer Res. 2019; 38(1):478.
PMID: 31775888
PMC: 6882349.
DOI: 10.1186/s13046-019-1479-2.
Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.
Hao X, Gao L, Deng X, Han F, Chen H, Jiang X
Cell Death Dis. 2019; 10(6):424.
PMID: 31142739
PMC: 6541591.
DOI: 10.1038/s41419-019-1663-5.
Comparison of iTRAQ and SWATH in a clinical study with multiple time points.
Jylha A, Nattinen J, Aapola U, Mikhailova A, Nykter M, Zhou L
Clin Proteomics. 2018; 15:24.
PMID: 30069167
PMC: 6065059.
DOI: 10.1186/s12014-018-9201-5.
Molecular Aspects of Wound Healing and the Rise of Venous Leg Ulceration: Omics Approaches to Enhance Knowledge and Aid Diagnostic Discovery.
Broszczak D, Sydes E, Wallace D, Parker T
Clin Biochem Rev. 2017; 38(1):35-55.
PMID: 28798504
PMC: 5548371.
Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
Cheng D, Zhang H, Yuan J, Li S, Yang Q, Fan C
Oncotarget. 2017; 8(16):26380-26393.
PMID: 28460433
PMC: 5432265.
DOI: 10.18632/oncotarget.15474.
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.
Chuang C, Greenside P, Rogers Z, Brady J, Yang D, Ma R
Nat Med. 2017; 23(3):291-300.
PMID: 28191885
PMC: 6453542.
DOI: 10.1038/nm.4285.
iTRAQ-Based Quantitative Proteomic Comparison of Early- and Late-Passage Human Dermal Papilla Cell Secretome in Relation to Inducing Hair Follicle Regeneration.
Zhang H, Zhu N, Huang K, Cai B, Zeng Y, Xu Y
PLoS One. 2016; 11(12):e0167474.
PMID: 27907131
PMC: 5132394.
DOI: 10.1371/journal.pone.0167474.
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.
Ye B, Sun H, Zhu X, Chai Z, Zhang Y, Ao J
Oncotarget. 2016; 7(20):29333-45.
PMID: 27121053
PMC: 5045399.
DOI: 10.18632/oncotarget.8787.
CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G, Xu Z, Zhang S, Shen Y, Qiu H, Zhu G
Dig Dis Sci. 2016; 61(8):2303-2314.
PMID: 27074923
DOI: 10.1007/s10620-016-4149-7.
Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R, Huffman K, Chu M, Zhang Y, Minna J, Yu Y
J Proteome Res. 2016; 15(2):477-86.
PMID: 26736068
PMC: 5001500.
DOI: 10.1021/acs.jproteome.5b00819.
Evaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy Samples.
Bourassa S, Fournier F, Nehme B, Kelly I, Tremblay A, Lemelin V
PLoS One. 2015; 10(5):e0125934.
PMID: 25950531
PMC: 4423961.
DOI: 10.1371/journal.pone.0125934.
